Kara Sabourin

Kara Sabourin has extensive work experience in the field of clinical operations. Kara currently serves as the Director of Clinical Operations at CG Oncology since December 2021. Prior to this, they held positions at Exelixis, starting as an Associate Director of Clinical Operations from April 2019 to March 2020, and then as a Director of Clinical Operations from March 2020 to December 2021.

Before joining Exelixis, Kara served as the Associate Director of Clinical Operations at SillaJen, where they provided oversight for a large global Phase 3 trial in oncolytic immunotherapy. Kara also handled data management for internally-managed early phase studies. During their tenure at SillaJen, they held various roles including Senior Clinical Data & Project Manager from November 2015 to September 2018, Clinical Data & Project Manager from January 2011 to November 2015, Clinical Project Manager from February 2009 to January 2011, and Clinical Research Associate II from February 2007 to February 2009.

Their career in the field of clinical research began at OneWorld Health, where they worked as a Clinical Research Associate from September 2005 to February 2007. Before entering the clinical research field, Kara gained experience as a Community Support Specialist at Toolworks from March 2001 to September 2005, and as a Mental Health Worker at Washtenaw County from March 1997 to January 2001.

Kara Sabourin pursued a Master of Public Health (MPH) degree in Public Health from the University of North Carolina at Chapel Hill from 2022 to 2024. Prior to that, between 1996 and 2001, they attended the University of Michigan, but no specific degree or field of study was mentioned.